• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Dr. Lal Pathlabs Ltd.
    30 Jan 2025
    3343.90
    1.83%
    Dr Lal Q3FY25 results: PAT jumps 19% to Rs 98 crore as volumes grow
    Business Standard
    As for Suburban Diagnostics, an arm of Dr Lal Pathlabs, revenue growth was 9.2 per cent in Q3
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. has gained 32.52% in the last 6 Months
    Dr Lal Path Labs Q3FY25 results: Net profit jumps 19% to Rs 96.7 crore
    Business Standard | 30 Jan 2025
    logo
    Thyrocare Technologies Ltd.
    27 Jan 2025
    1223.70
    -2.46%
    'EMI gets high-end cars and artificial high...': Thyrocare founder's choice for a ride sparks debate
    'EMI gets high-end cars and artificial high...': Thyrocare founder's choice for a ride sparks debate
    Business Today
    Dr. Velumani's preference for economical travel is not new. In a prior post, he shared his decision to take a local train in Mumbai instead of a car, cutting his commute from 70 minutes to just 18. However costly the car is, in Mumbai for time management, just board a Local, he explained.
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologies Ltd. has gained 81.17% in the last 6 Months
    logo
    Thyrocare Technologies Ltd.
    24 Jan 2025
    1223.70
    -2.46%
    Thyrocare Technologies Q3 Results 2025 on 24 Jan, 2025: profit rise by 24.5% YOY, profit at 19.11 crore and revenue at 165.92 crore
    Thyrocare Technologies Q3 Results 2025 on 24 Jan, 2025: profit rise by 24.5% YOY, profit at 19.11 crore and revenue at 165.92 crore
    livemint
    Thyrocare Technologies Q3 Results 2025 on 24 Jan, 2025: Revenue increased by 23.14% YoY & profit increased by 24.5% YoY, profit at 19.11 crore and revenue at 165.92 crore
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologies Ltd. is trading above its 200 day SMA of 965.2
    Tech Query: What is the outlook for Thyrocare Technologies and Karnataka Bank?
    Business Line | 23 Jan 2025
    logo
    Dr. Lal Pathlabs Ltd.
    23 Jan 2025
    3343.90
    1.83%
    Dr Lal PathLabs sets board meeting date to declare Q3 results 2025, interim dividend
    Dr Lal PathLabs sets board meeting date to declare Q3 results 2025, interim dividend
    livemint
    Dr Lal PathLabs will announce its Q3 results for FY25 on January 30, 2025. The Board of Directors will also discuss a third interim dividend for the financial year.
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. has gained 32.52% in the last 6 Months
    logo
    Dr. Lal Pathlabs Ltd.
    12 Jan 2025, 10:13PM
    3343.90
    1.83%
    Steady heartbeat of growth in diagnostics stock keeps sector pulsing
    Business Standard
    Realisation growth for Dr Lal PathLabs and Vijaya Diagnostic Centre is projected to remain flat compared to the previous year
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. is trading above all available SMAs
    logo
    Suraksha Diagnostic Ltd.
    07 Jan 2025
    310.30
    -0.77%
    HMPV In India: What Are The Tests To Detect It, And How Much Do They Cost
    HMPV In India: What Are The Tests To Detect It, And How Much Do They Cost
    NDTV Profit
    Dr Abhirup Sarkar, laboratory director at Suraksha Diagnostics, told NDTV Profit that the virus is typically detected using the PCR method, the same technique employed to identify the coronavirus.
    Copy LinkShare onShare on Share on Share on
    Suraksha Diagnostic Ltd. is trading below its 100 day SMA of 314.1
    logo
    Dr. Lal Pathlabs Ltd.
    06 Jan 2025
    3343.90
    1.83%
    HMPV Outbreak: Diagnostics Stocks Buzz As India Reports Two Cases, Vijaya Diagnostics, Dr. Lal Path Labs Up
    HMPV Outbreak: Diagnostics Stocks Buzz As India Reports Two Cases, Vijaya Diagnostics, Dr. Lal Path Labs Up
    NDTV Profit
    Vijaya Diagnostics and Dr. Lal Path Labs shares gained as much as 2.9% each, while Metropolis Healthcare Ltd. and Thyrocare Technologies Ltd. jumped 1.8%.
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. has an average target of 3111.40 from 5 brokers.
    logo
    Medi Assist Healthcare Services Ltd.
    24 Dec 2024
    507.75
    -1.56%
    The best proxy to potentially profit from India's health insurance boom
    The best proxy to potentially profit from India's health insurance boom
    livemint
    Medi Assist, India's leading TPA, benefits from rising health insurance penetration. With robust growth, market dominance, and M&A, it's a stable proxy to ride India's health insurance boom.
    Copy LinkShare onShare on Share on Share on
    Medi Assist Healthcare Services Ltd. is trading below all available SMAs
    logo
    Metropolis Healthcare Ltd.
    19 Dec 2024
    2063.00
    -2.91%
    Core acquisition adds to Metropolis Healthcare's long-term growth plans
    Business Standard
    Market share gains in the B2C portfolio are visible and Tier III+ markets are likely to contribute to the patient volume growth guidance
    Copy LinkShare onShare on Share on Share on
    Metropolis Healthcare Ltd.'s price crossed below 30Day SMA today
    logo
    Inventurus Knowledge Solutions Ltd.
    19 Dec 2024
    Insider Trades
    1540.70
    0.36%
    Inventurus Knowledge Solutions block deal: Norges Bank buys 34 lakh shares worth Rs 652 crore
    Inventurus Knowledge Solutions block deal: Norges Bank buys 34 lakh shares worth Rs 652 crore
    Economic Times
    Norges Bank, on behalf of the Government Pension Fund Global, acquired 16.59 lakh and 17.50 lakh shares of Inventurus Knowledge Solutions at Rs 1,923.92 and Rs 1,899.67 per share, respectively. IKS stock debuted at Rs 1,900, a 43% premium to its issue price of Rs 1,329, and closed at Rs 2,030 on Thursday, up 6.84% or Rs 130 over the listing price.
    Copy LinkShare onShare on Share on Share on
    Inventurus Knowledge Solutions Ltd. is trading below all available SMAs
    Bumper Debut! Inventurus Knowledge Solutions shares list at 43% premium
    Business Standard | 19 Dec 2024 1 more
    Inventurus Knowledge Solutions IPO listing date today. GMP, experts signal strong debut of shares on BSE, NSE
    livemint | 19 Dec 2024
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd